The acquisition will advance therapies for treatment-resistant depression and other mental health conditions
Source: PMLiVE
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.